Tus-Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 275.090 million compared to CNY 315.034 million a year ago. Operating income was CNY 27.785 million compared to CNY 52.103 million a year ago. Net income was CNY 22.722 million compared to CNY 42.442 million a year ago. Basic earnings per share from continuing operations was CNY 0.0949 compared to CNY 0.1772 a year ago.